The pharmaceutical company Nanotheraputics has entered a two year agreement with the National Cancer Institute to develop a deliver system for a human immunodeficiency virus (HIV) oral vaccine. The targeted area of delivery is the lower gastrointestinal tract. To learn more about how nanoparticles will be used in the oral HIV vaccine.
Full Article

German company Buhler Partec is one of the first companies to have their nanoparticle risk system certified. While there are no worldwide laws or regulations for nanoparticles, Buhler Partec introduced an internal system to identify risks and implement control methods. To read more about the system at Buhler Partec.
Full Article

IBM working with ETH Zurich and Swiss Federal Institute of Technology have developed a technique to print with molecules. Nanoparticles are arranged precisely on a soft rubber template with microscopic pits. A silicon or glass plate can be laid on the template and the particles transferred onto the plate. To learn more about this process.
Full Article

A nanoparticle that can be used from vaccines created by researchers at the EPFL in Switzerland may be more effective, cheaper to make, and may have fewer side effects due to vaccination. The recent breakthrough may allow for vaccinating against malaria and hepatitis with a single injection. The estimated cost of producing a nanoparticle based vaccine is a dollar a dose. To learn more about this promising public health breakthrough.
Full Article

Researchers at the Old Dominion University have developed a silver nanoparticle biosensor that allows them to trace protein receptors on the cell surface. The researchers attached a nanoparticle to the antibody immunoglobulin G (IgG) with allowed for them to observe the binding activity of a single protein receptor on a single cell. To learn more about this work.
Full Article

The research company Insert Therapeutics Inc. received a patent for it nanoparticle based cancer drug. The nanoparticle serves as a delivery vehicle for the anti-cancer compound camptothecin. To learn more about this potential cancer treatment option.
Full Article